Women with autoimmune diseases waited about four years for a diagnosis while men sometimes waited three months, a British survey published in eClinicalMedicine has found.
The survey, reported on Sunday, reached 6,607 adults online — 91.2% of them women, most based in the United Kingdom. Women were far likelier to be misdiagnosed or have treatment delayed, with symptoms at times dismissed as “psychological.”
Sydnae Taylor, a doctoral researcher at the University of Oxford and a co-author of the study, put the pattern bluntly.
“Women in particular felt not listened to or not heard or not believed by their medical professionals,” said Taylor.
The numbers show the gap runs through the diagnostic journey. Among the survey respondents, 49.7% of men said they were diagnosed within a year of their first symptoms, against 39.7% of women. The gap persisted after adjustment for age, disease group, continent and household finances, according to the European Medical Journal’s report on the findings.
Four Years Versus Three Months
| Measure (self-reported) | Women | Men |
|---|---|---|
| Diagnosed within one year of symptom onset | 39.7% | 49.7% |
| Delays of four years or more | 31.8% | 25.5% |
| 11 or more clinician visits before diagnosis | 26.2% | 18.4% |
| Perceived psychiatric misdiagnosis | 43.3% | 32.7% |
| Perceived psychosomatic misdiagnosis | 33.9% | 21.5% |
The adjusted odds also favored men: women had higher odds of psychiatric misdiagnosis (OR 1.46) and psychosomatic misdiagnosis (OR 1.74), per the European Medical Journal’s write-up. Misdiagnosis with another physical disease, by contrast, did not differ significantly by sex — 47.6% of men versus 43.5% of women.
Rates varied widely by condition. For autoimmune encephalitis and undifferentiated connective tissue disease, more than half of patients reported being wrongly told their illness was mental health or psychosomatic in nature. Polymyalgia rheumatica, type 1 diabetes and rheumatoid arthritis each came in under 25%.
Disorders that show outward signs or have more definitive biomarkers tended to fare better. The highest rates of misdiagnosis with a different physical illness appeared in inflammatory bowel disease (57.9%) and vasculitis (57%).
Taylor told NBC News that misdiagnosis is more likely when symptoms are “invisible” — not picked up on a blood test, or involving pain, fatigue and neurological complaints such as tingling. In those cases, an accurate diagnosis rests on doctors listening to and believing the patient.
Why Symptoms Are Hard to Pin Down
In autoimmune diseases — type 1 diabetes, multiple sclerosis, inflammatory bowel disease and psoriasis among them — the immune system turns against the body itself. More than 23 million people in the United States have one, and most are women. Around 90% of people with lupus are women, according to the Lupus Foundation of America.
Many of these disorders share early symptoms — fatigue, dizziness, low-grade fever, alongside stress, anxiety and depression — which makes them hard to tell apart. Dr. Saira Z. Sheikh, director of the UNC Rheumatology Lupus Clinic in Chapel Hill, North Carolina, told NBC News that women’s symptoms differ in one crucial way from men’s.
“they develop over time, so it’s often hard to recognize right at the beginning,” said Sheikh. Symptoms can appear in childhood and persist through adulthood.
Why women carry more of the risk remains unsettled. Mayo Clinic research has pointed to differences in the microbiome and sex hormones, and to women’s higher levels of antibodies linked to autoimmune disease. A 2024 Stanford Medicine study found clues in a molecule connected to the X chromosome, NBC reported.
How the Survey Was Built — and Its Limits
Researchers recruited through social media, patient support groups and community groups serving underserved populations, including religious groups and homeless people, and translated the survey into five languages. Participants reported when symptoms began, how many clinicians they had consulted and whether they had been misdiagnosed.
The European Medical Journal’s account flags the caveats: the findings are exploratory and rest on self-reported, perceived misdiagnoses, which carry recall and selection bias. Most respondents were White and UK-based, and only 583 were men.
The study itself lists the European data as an international cross-sectional survey by Sloan M et al., published in eClinicalMedicine in 2026. Perceived misdiagnosis, the journal notes, has been linked to reduced trust and reluctance to seek care — one reason clinicians are advised to consider autoimmune disease early in patients with multisystem or initially unexplained symptoms.
The reaction online was immediate. The survey prompted women to share their own accounts of symptoms attributed to stress or psychological problems before the underlying illness was found, according to inkl’s aggregation of coverage on Tuesday, renewing debate over whether women’s symptoms get equal attention in the exam room.
Diagnosis aside, treatment starts with recognition — and early recognition, the researchers suggest, may rest on something simpler than any test. Sheikh’s advice to clinicians cut the same way: “We shouldn’t assume that women’s symptoms are psychological simply because the initial investigations are inconclusive.”